Ondine Biomedical Inc (OBI) - Cash Flow Conversion Efficiency

Latest as of December 2025: -3.853x

Based on the latest financial reports, Ondine Biomedical Inc (OBI) has a cash flow conversion efficiency ratio of -3.853x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-13.44 Million ≈ $-1.64K USD) by net assets (GBX3.49 Million ≈ $424.53 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See OBI defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Ondine Biomedical Inc - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Ondine Biomedical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ondine Biomedical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ondine Biomedical Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tarku Resources Ltd V:TKU	-0.015x
Ribbon Acquisition Corp Rights NASDAQ:RIBBR	N/A
EJF Investments Ltd LSE:EJFI	0.036x
Alveen PA:MLALV	N/A
SPOTLITE360 IOT SOLUTIONS F:87A0	N/A
Aker Horizons AS OL:AKH	-0.007x
Braemar Plc LSE:BMS	0.012x
Geneuro SA PA:GNRO	0.393x

Annual Cash Flow Conversion Efficiency for Ondine Biomedical Inc (2001–2025)

The table below shows the annual cash flow conversion efficiency of Ondine Biomedical Inc from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see OBI company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX3.49 Million ≈ $424.53	GBX-23.90 Million ≈ $-2.91K	-6.851x	-204.17%
2024-12-31	GBX6.88 Million ≈ $836.73	GBX-15.49 Million ≈ $-1.88K	-2.252x	+65.60%
2023-12-31	GBX2.08 Million ≈ $253.68	GBX-13.65 Million ≈ $-1.66K	-6.548x	-366.49%
2022-12-31	GBX11.64 Million ≈ $1.42K	GBX-16.34 Million ≈ $-1.99K	-1.404x	-231.98%
2021-12-31	GBX29.66 Million ≈ $3.61K	GBX-12.54 Million ≈ $-1.53K	-0.423x	-325.93%
2020-12-31	GBX-33.83 Million ≈ $-4.12K	GBX-6.33 Million ≈ $-770.30	0.187x	-35.38%
2019-12-31	GBX-26.07 Million ≈ $-3.17K	GBX-7.55 Million ≈ $-918.74	0.290x	-48.60%
2018-12-31	GBX-17.90 Million ≈ $-2.18K	GBX-10.08 Million ≈ $-1.23K	0.563x	-29.97%
2017-12-31	GBX-6.55 Million ≈ $-796.70	GBX-5.27 Million ≈ $-640.96	0.805x	+108.26%
2010-12-31	GBX279.19K ≈ $33.97	GBX-2.72 Million ≈ $-330.96	-9.743x	-262.05%
2009-12-31	GBX1.28 Million ≈ $155.48	GBX-3.44 Million ≈ $-418.39	-2.691x	+59.70%
2008-12-31	GBX1.34 Million ≈ $162.71	GBX-8.93 Million ≈ $-1.09K	-6.677x	-508.20%
2007-12-31	GBX10.84 Million ≈ $1.32K	GBX-11.90 Million ≈ $-1.45K	-1.098x	-67.96%
2006-12-31	GBX16.59 Million ≈ $2.02K	GBX-10.84 Million ≈ $-1.32K	-0.654x	-28.61%
2005-12-31	GBX16.50 Million ≈ $2.01K	GBX-8.39 Million ≈ $-1.02K	-0.508x	-274.72%
2003-08-31	GBX-227.62K ≈ $-27.70	GBX-66.20K ≈ $-8.06	0.291x	+264.97%
2002-08-31	GBX-143.28K ≈ $-17.43	GBX25.26K ≈ $3.07	-0.176x	-396.57%
2001-08-31	GBX1.39 Million ≈ $169.63	GBX-49.50K ≈ $-6.02	-0.036x	--

About Ondine Biomedical Inc

LSE:OBI UK Biotechnology

Market Cap

$916.61K

GBX7.53 Billion GBX

Market Cap Rank

#30562 Global

#823 in UK

Share Price

GBX14.50

Change (1 day)

+0.00%

52-Week Range

GBX8.00 - GBX18.00

All Time High

GBX58.50